Indian Navy Medicines Tender Uttara Kannada Karnataka 2025 - ISI/ISO Standards & 25% Quantity Option

Tender Overview

The Indian Navy invites bids for a broad slate of pharmaceutical products, including FEBUXOSTAT, METHYLPHENIDATE, RIFAMPICIN, ISONIAZID, METHOTREXATE, ACENOCOUMROL, CARVEDILOL, ECOSPRIN, ROSUVASTATIN, AMLODIPINE, RAMIPRIL, MUPIROCIN OINT, MESALAMINE, CIPROFLOXACIN, DEXAMETHASONE, PAROXETINE XR, QUETIAPINE, LINEZOLID, FLAVONOIDS, TAMSULOSIN, ETHAMBUTOL, METHYLPREDNISOLONE, SULPHAMETHOXAZOLE/TRIMETHOPRIM, and DAPAGLIFLOZIN, among 22 items. Estimated value is ₹22.0 million. Location: Uttara Kannada, Karnataka. The procurement scope covers multi-therapeutic tablets, capsules, ointments, suppositories, and liquids. A 25% quantity option is allowed during contract placement and currency, with delivery windows tied to the original delivery order dates. Submission requires vendor code creation and standard banking documents.

Key differentiators include a flexible option clause, GSTIN/PAN verification, and EFT Mandate requirements. The tender emphasizes standard financial documentation and delivery discipline, with a focus on timely fulfillment of pharmaceutical supplies to naval facilities.

Technical Specifications & Requirements

• Total items: 22 pharmacological products spanning anti-infectives, cardiovasculars, anti-inflammatory, analgesics, psychotropics, GI agents, and ophthalmic/dermatology preparations
• Delivery terms: Option to increase/decrease quantity by up to 25%; additional delivery time calculation: (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days
• Payment terms: EFT-based, with documentation supporting PAN and GST compliance, and bank-certified EFT mandate
• Documentation prerequisites: PAN, GSTIN, cancelled cheque, EFT mandate (bank-certified) for bid submission
• Tender context: Buyer-added terms require adherence to the option clause and delivery sequencing from the last delivery order date
• Standards/Compliance: Explicit standards not listed; bidders must align with general pharmaceutical supply controls and banking documentation requirements

Terms, Conditions & Eligibility

• EMD / Bid security: Not specified in available data; bidders must review final tender terms for deposit requirements
• Delivery timeline: Delivery period linked to original delivery order date; extended periods depend on option clause calculations
• Experience & turnover: Not specified; bidders should demonstrate capability to supply multi-therapeutic pharmaceutical items to government units
• Documents for bid submission: PAN, GSTIN, Cancelled Cheque, EFT Mandate (bank-certified)
• Payment terms: EFT-based payments post-delivery per contract terms
• Warranty/penalties: Not specified in provided terms; verify during bid submission